Bulletin
Investor Alert

Market Pulse Archives

Dec. 15, 2021, 7:29 a.m. EST

Medtronic warned by FDA about manufacturing facility for insulin pumps

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Medtronic PLC (MDT)
  • X
    S&P 500 Index (SPX)

or Cancel Already have a watchlist? Log In

By Jaimy Lee

Shares of Medtronic /zigman2/quotes/206816578/composite MDT -2.53% gained 0.3% in premarket trading on Wednesday after the company said it received a warning letter from the Food and Drug Administration following an inspection at a factory that makes its MiniMed 600 series insulin infusion pump and a remote-controller device for MiniMe 508 and Paradigm pumps. The company said it will make corrections to quality system requirements. Medtronic's stock is down 4.6% for the year, while the broader S&P 500 /zigman2/quotes/210599714/realtime SPX -4.04% is up 25.4%.

/zigman2/quotes/206816578/composite
US : U.S.: NYSE
$ 103.57
-2.69 -2.53%
Volume: 4.13M
May 18, 2022 4:00p
P/E Ratio
28.55
Dividend Yield
2.43%
Market Cap
$142.55 billion
Rev. per Employee
$353,167
loading...
/zigman2/quotes/210599714/realtime
US : S&P US
3,923.68
-165.17 -4.04%
Volume: 2.71B
May 18, 2022 4:56p
loading...

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.